Polymer Formulations for nasolacrimal stimulation
US9956397B2 · kind B2 · utility
24Cited by
162References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 11, 2017 |
| Grant date | May 1, 2018 |
| Priority date | — |
| Expiry date | Sep 11, 2037 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10T29/49885
- WIPO fieldMedical technology
- WIPO sectorInstruments
Abstract
Described herein are polymer formulations for facilitating electrical stimulation of nasal or sinus tissue. The polymer formulations may be hydrogels that are prepared by a UV cross-linking process. The hydrogels may be included as a component of nasal stimulator devices that electrically stimulate the lacrimal gland to improve tear production and treat dry eye. Additionally, devices and methods for manufacturing the nasal stimulators, including shaping of the hydrogel, are described herein.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.